By Doris Obinna
The World Health Organisation (WHO) has warned that sub-Saharan Africa bears the highest rates of deaths associated with antimicrobial resistance (AMR), calling for urgent investment in surveillance, laboratory capacity and responsible use of medicines to contain the growing threat.
WHO Regional Director for Africa, Dr Mohamed Janabi, said drug-resistant infections were undermining decades of medical progress, making previously treatable infections harder to cure and putting millions of lives at risk.
Janabi, in his message to mark the 2026 World Antimicrobial Resistance Awareness Week (WAAW), observed from 18 to 24 November, disclosed that bacterial AMR was associated with an estimated 4.7 million deaths globally in 2021, with Africa carrying the heaviest mortality burden.
He warned that the growing resistance of bacteria, viruses, fungi and parasites to medicines threatened the gains made through the discovery of antibiotics, which had transformed the treatment of infections and made procedures such as surgery, cancer treatment and organ transplantation safer.
Under the theme “One Health, One Action: Prevent AMR Now”, the WHO regional director stressed that tackling the crisis required coordinated action across human, animal, plant and environmental health.
He identified inappropriate use of antimicrobials in humans and animals, poor infection prevention, inadequate access to clean water and sanitation, and unsafe waste disposal as major factors accelerating the emergence and spread of resistant organisms.
Despite the challenges, Janabi said countries in the WHO African Region had recorded progress in developing systems to tackle AMR, although implementation remained uneven.
According to him, all 47 countries in the region now have national action plans on AMR and are enrolled in WHO’s Global Antimicrobial Resistance and Use Surveillance System, while 44 have the capacity to conduct susceptibility testing for priority bacterial pathogens.
He said 36 countries had also adopted WHO’s Access, Watch and Reserve classification of antibiotics, a framework designed to promote appropriate prescribing and reduce the misuse of medicines.
The global target, he noted, was to ensure that at least 70 per cent of antibiotics used in human health came from the Access group by 2030.
Other News
Janabi, however, warned that having policies and action plans was not enough without effective implementation, funding and measurable results.
He disclosed that the number of countries with functional One Health AMR governance mechanisms had increased from 15 in 2023 to 29 in 2026, reflecting improved coordination among sectors responsible for tackling the threat.
Calling for stronger government commitment, he urged countries to translate their national action plans into adequately funded interventions, with clear responsibilities and measurable targets.
He said domestic investment should prioritise laboratories, disease surveillance and responsible antimicrobial use, while ensuring that people could access quality-assured medicines and diagnostic services when needed.
The WHO official also called for stronger infection prevention measures, including vaccination, improved hygiene, clean water, sanitation and effective infection control in healthcare facilities and farms.
He stressed the need for safer management of waste and wastewater to prevent resistant organisms from spreading.
He urged healthcare professionals, veterinary workers and those in agriculture to use antimicrobials responsibly, while calling on researchers, pharmaceutical companies and development partners to support national priorities and expand equitable access to diagnostics and treatment.
Janabi also appealed to communities, young people, educators and the media to intensify public awareness, advising people to keep vaccinations up to date, practise regular hand hygiene, take antibiotics only when prescribed by qualified health professionals and avoid sharing leftover medicines.
He reaffirmed WHO’s commitment to working with governments and partners to strengthen the One Health response, warning that the effectiveness of lifesaving medicines must be protected for present and future generations.

Follow Us on Google
